|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
DE2830469A1
(de)
*
|
1978-07-11 |
1980-01-24 |
Bayer Ag |
Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten
|
|
DE2835069A1
(de)
*
|
1978-08-10 |
1980-02-21 |
Bayer Ag |
N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
|
|
DE2839309A1
(de)
*
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
|
DE2848117A1
(de)
*
|
1978-11-06 |
1980-05-14 |
Bayer Ag |
Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
|
|
JPS55118415A
(en)
*
|
1979-02-28 |
1980-09-11 |
Pii Papahadojiyopo Dometoriosu |
Method of encapsulating biologically active substance in lipoid cell
|
|
DE2925943A1
(de)
*
|
1979-06-27 |
1981-01-29 |
Bayer Ag |
1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
DE2942365A1
(de)
*
|
1979-10-19 |
1981-05-14 |
Bayer Ag, 5090 Leverkusen |
2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
JPS56108767A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Bismoranoline derivative
|
|
JPS56108768A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Cinnamylmoranoline derivative
|
|
DE3007078A1
(de)
*
|
1980-02-26 |
1981-09-10 |
Bayer Ag, 5090 Leverkusen |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
|
|
DE3620645A1
(de)
*
|
1985-12-20 |
1987-07-02 |
Bayer Ag |
3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5192772A
(en)
*
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
|
US4999360A
(en)
*
|
1987-12-21 |
1991-03-12 |
Monsanto Company |
Method of inhibiting virus
|
|
US5089520A
(en)
*
|
1987-12-21 |
1992-02-18 |
Monsanto Company |
Method of inhibiting virus
|
|
US4849430A
(en)
*
|
1988-03-09 |
1989-07-18 |
Monsanto Company |
Method of inhibiting virus
|
|
EP0344383A1
(fr)
*
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Inhibiteurs d'alpha-glucosidase
|
|
US5043416A
(en)
*
|
1988-09-26 |
1991-08-27 |
Monsanto Company |
Method of inhibiting virus
|
|
US5310745A
(en)
*
|
1988-11-03 |
1994-05-10 |
G. D. Searle & Co. |
Antiviral compounds
|
|
US4937357A
(en)
*
|
1988-11-03 |
1990-06-26 |
G. D. Searle & Co. |
Intermediates for antiviral compounds
|
|
US5221746A
(en)
*
|
1988-11-03 |
1993-06-22 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
|
US4876268A
(en)
*
|
1988-11-03 |
1989-10-24 |
G. D. Searle & Co. |
Antiviral compounds and use thereof
|
|
US5003072A
(en)
*
|
1988-11-03 |
1991-03-26 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
|
US4973602A
(en)
*
|
1988-11-03 |
1990-11-27 |
G. D. Searle & Co. |
Antiviral compounds and a method of use thereas
|
|
US5144037A
(en)
*
|
1988-11-03 |
1992-09-01 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-d-glucitol derivatives
|
|
US4957926A
(en)
*
|
1988-12-22 |
1990-09-18 |
Monsanto Company |
Method of treating herpesviruses
|
|
US5103008A
(en)
*
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
|
US5043273A
(en)
*
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
|
US5252587A
(en)
*
|
1990-04-27 |
1993-10-12 |
Merrell Dow Pharmaceuticals, Inc. |
N-derivatives of 1-deoxy nojirimycin
|
|
EP0453692A1
(fr)
*
|
1990-04-27 |
1991-10-30 |
Merrell Dow Pharmaceuticals Inc. |
Nouveaux dérivés de nojirimycine
|
|
US5536732A
(en)
*
|
1990-04-27 |
1996-07-16 |
Merrell Pharmaceuticals Inc. |
N-derivatives of 1-deoxy nojirimycin
|
|
US5151519A
(en)
*
|
1990-05-07 |
1992-09-29 |
G. D. Searle & Co. |
Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
|
|
US5504078A
(en)
*
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
|
US5342951A
(en)
*
|
1992-04-01 |
1994-08-30 |
G.D. Searle & Co. |
2- and 3-sulfur derivatives of 1,5-iminosugars
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
US6291657B1
(en)
*
|
1993-05-13 |
2001-09-18 |
Monsanto Company |
Deoxygalactonojirimycin derivatives
|
|
US5798366A
(en)
*
|
1993-05-13 |
1998-08-25 |
Monsanto Company |
Method for treatment of CNS-involved lysosomal storage diseases
|
|
CA2181033C
(fr)
*
|
1994-01-13 |
2007-09-04 |
Timothy M. Block |
Utilisation de derives n-alkyle de 1,5-didesoxy-1,5-imino-d-glucitol pour le traitement des infections a virus de l'hepatite b
|
|
US20030100532A1
(en)
*
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
|
PT1030839E
(pt)
|
1997-11-10 |
2004-05-31 |
Searle & Co |
Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
|
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
|
DE69932154T2
(de)
|
1998-02-12 |
2007-05-31 |
G.D. Searle Llc, Chicago |
Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
|
|
ATE402701T1
(de)
*
|
1999-02-12 |
2008-08-15 |
United Therapeutics Corp |
N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
|
|
JP2003505501A
(ja)
|
1999-02-12 |
2003-02-12 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウィルス感染の処置のためのグルカミン化合物
|
|
US20050032841A1
(en)
*
|
1999-04-20 |
2005-02-10 |
Steven Walkley |
Therapeutic compositions and methods of treating glycolipid storage related disorders
|
|
GB9909066D0
(en)
|
1999-04-20 |
1999-06-16 |
Oxford Glycosciences Uk Ltd |
Therapies
|
|
EA009646B1
(ru)
*
|
2003-05-30 |
2008-02-28 |
Рэнбакси Лабораториз Лтд. |
Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
|
|
EP1811991B1
(fr)
*
|
2004-11-10 |
2018-11-07 |
Genzyme Corporation |
Traitement du diabete de type 2 en utilisant d'inhibiteurs de la synthese des glycosphingolipides
|
|
JP2009514851A
(ja)
*
|
2005-11-08 |
2009-04-09 |
ランバクシー ラボラトリーズ リミテッド |
(3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
|
|
TW200744583A
(en)
*
|
2006-03-14 |
2007-12-16 |
Ranbaxy Lab Ltd |
Statin stabilizing dosage formulations
|
|
SI2032134T1
(sl)
|
2006-05-09 |
2015-10-30 |
Genzyme Corporation |
Postopki zdravljenja bolezni zamaščenih jeter, ki obsegajo inhibicijo sintezo glukosfingolipida
|
|
BRPI0714361A2
(pt)
*
|
2006-07-14 |
2013-03-26 |
Ranbaxy Lab Ltd |
polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
|
|
KR20090057035A
(ko)
*
|
2006-08-21 |
2009-06-03 |
유나이티드 세러퓨틱스 코오포레이션 |
바이러스 감염의 치료를 위한 병용 요법
|
|
US8097728B2
(en)
*
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
|
EP2594564B1
(fr)
*
|
2007-05-31 |
2016-09-28 |
Genzyme Corporation |
Inhibiteurs de glucosylcéramide synthase de type 2-acylaminopropanol
|
|
CN101888840A
(zh)
|
2007-10-05 |
2010-11-17 |
简詹姆公司 |
使用脑酰胺衍生物治疗多囊性肾疾病的方法
|
|
CA2731685A1
(fr)
|
2008-07-28 |
2010-02-04 |
Genzyme Corporation |
Inhibition de synthase de glucosylceramide pour le traitement du glomerulopathie avec collapsus, et d'un autre trouble glomerulaire
|
|
EP3078373A1
(fr)
|
2008-10-03 |
2016-10-12 |
Genzyme Corporation |
Inhibiteurs de glucosylcéramide synthase de type 2-acylaminopropanol
|
|
EP2398321B1
(fr)
|
2009-02-23 |
2015-11-25 |
United Therapeutics Corporation |
Iminosucres et procedes de traitement de maladies virales
|
|
EP2400843B1
(fr)
*
|
2009-02-24 |
2015-11-11 |
United Therapeutics Corporation |
Iminosucres et procédés de traitement d'infections arénavirales
|
|
ES2524361T3
(es)
*
|
2009-06-12 |
2014-12-05 |
United Therapeutics Corporation |
Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
|
|
CA2772813A1
(fr)
*
|
2009-09-04 |
2011-03-10 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Iminosucres et procedes de traitement de maladies filovirales
|
|
JP5653438B2
(ja)
*
|
2009-09-04 |
2015-01-14 |
ユナイテッド セラピューティクス コーポレイション |
オルトミクソウイルス感染の治療方法
|
|
CA2772807A1
(fr)
*
|
2009-09-04 |
2011-03-10 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Procedes de traitement d'infections poxvirales
|
|
BR112018072298A2
(pt)
|
2016-05-02 |
2019-02-12 |
Florida State University Research Foundation, Inc. |
tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase
|
|
US11369592B2
(en)
|
2020-02-21 |
2022-06-28 |
Florida State University Research Foundation, Inc. |
Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
|